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ABSTRACT
Wound-colonizing microorganisms can form complex and dynamic polymicrobial communities
where pathogens and commensals may co-exist, cooperate or compete with each other. The
present study was aimed at identifying possible interactions between different bacteria isolated
from the same chronic wound of a patient with the genetic blistering disease epidermolysis bullosa
(EB). Speciﬁcally, this involved two different isolates of the human pathogen Staphylococcus aureus,
and isolates of Bacillus thuringiensis and Klebsiella oxytoca. Particular focus was attributed to
interactions of S. aureus with the two other species, because of the high staphylococcal prevalence
among chronic wounds. Intriguingly, upon co-cultivation, none of the wound isolates inhibited each
other’s growth. Since the extracellular proteome of bacterial pathogens is a reservoir of virulence
factors, the exoproteomes of the staphylococcal isolates in monoculture and co-culture with B.
thuringiensis and K. oxytoca were characterized by Mass Spectrometry to explore the inherent
relationships between these co-exisiting bacteria. This revealed a massive reduction in the number
of staphylococcal exoproteins upon co-culturing with K. oxytoca or B. thuringiensis. Interestingly, this
decrease was particularly evident for extracellular proteins with a predicted cytoplasmic localization,
which were recently implicated in staphylococcal virulence and epidemiology. Furthermore, our
exoproteome analysis uncovered potential cooperativity between the two different S. aureus
isolates. Altogether, the observed exoproteome variations upon co-culturing are indicative of








Studies on pathogenic bacteria, either in vitro or in animal
models, commonly address the respective bacteria as
secluded species. Such studies do not consider the natural
ecosystem of bacteria that colonize and invade the human
body, which may happen in competition or cooperation
with the existing microbiota and other pathogens. Further-
more, although bacteria-host interactions are the key to
understanding the pathophysiology of infectious diseases, it
is also important to scrutinize the parallel relationships
between different bacterial species. This segment of micro-
bial ecology may also elucidate how pathogens adjust their
metabolism and other adaptive responses to survive and
persist in the human body.
An example of a well-adapted bacterium associated
with humans and animals, both as a commensal and as a
pathogen, is Staphylococcus aureus [1, 2]. This bacterium
has an exceptional ability to adapt and evolve swiftly
into multidrug resistant lineages, as shown since the clin-
ical introduction of penicillin and subsequently devel-
oped antibiotics [3, 4]. S. aureus is able to cause a wide
range of afﬂictions ranging from impetigo and upper
respiratory tract infections to osteomyelitis, endocarditis
and sepsis. The fruitless attempts to develop a vaccine
against S. aureus [5, 6]. suggest the need for a better
understanding of community interactions and the
respective metabolic networks. This need is further
underpinned by the high prevalence of infections caused
by methicillin-resistant S. aureus (MRSA) in hospitals
and communities worldwide [7, 8]. Nevertheless, the
vast majority of molecular studies on the virulence of S.
aureus have investigated this pathogen in isolation.
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In the present study, we explored the possible interac-
tions between two phenotypically different S. aureus iso-
lates from a chronic wound of a patient with epidermolysis
bullosa (EB) and two other bacterial species, Bacillus thur-
ingiensis and Klebsiella oxytoca, isolated from the same
wound. EB is a genetic blistering disease characterized by
the development of chronic wounds upon simple mechani-
cal trauma. It was previously shown that S. aureus is an
important wound colonizer in patients with EB, where a
patient can carry several S. aureus types in a single wound,
and autoinoculation from the upper respiratory tract can
occur [9–15]. Notably, next to S. aureus, also other bacteria
are known to colonize the wounds of EB patients [16].
Considering these colonization characteristics and the high
prevalence of S. aureus in the chronic wounds of patients
with EB [15], we decided to study the interactions of S.
aureus wound isolates with coexisting B. thuringiensis or K.
oxytoca isolates. In particular, we focused attention on the
extracellular proteomes (in short, exoproteomes) of these
bacteria, because the exoproteome is a major reservoir of
virulence factors [17].
B. thuringiensis is a Gram-positive, spore-forming aero-
bic bacterium that is commonly used as a safe bioinsecti-
cide since it produces pore-forming proteins that are toxic
for insect larvae [18]. It belongs to the same group as Bacil-
lus anthracis and Bacillus cereus, the etiologic agents of
anthrax and the “fried rice syndrome” (i.e. food poisoning),
respectively [19, 20]. B. thuringiensis, unlike the other two,
is not known as a major human pathogen [21]. However, it
has been reported that this bacterium may be responsible
for opportunistic pulmonary infections in susceptible sub-
jects [22, 23]. On the other hand, the Gram-negative bacte-
rium K. oxytoca is clearly regarded as an opportunistic
pathogen. It is commonly found on mucosal surfaces of
mammals, including the nasopharynx and colon of
humans [24]. Klebsiella species are the second most
common cause of nosocomial Gram-negative bacteremia
after Escherichia coli, and they are often involved in urinary
tract infections in risk group patients and neonatal sepsis
[25–28].
Altogether, the present study was aimed at explor-
ing the potentially synergistic or competitive relation-
ships between S. aureus and two different classes of
bacteria that are, in principle, capable of colonizing
and invading the human body, thereby causing dis-
ease. Our speciﬁc objective was to unravel the bacte-
rial response patterns using the exoproteome as a
read-out. To this purpose, two different S. aureus iso-
lates were, respectively, co-cultured with B. thurin-
giensis (Bt) or K. oxytoca (Ko) isolates from the same
wound environment, and the exoproteomes of indi-
vidually or co-cultured bacteria were analyzed by
Mass Spectrometry (MS).
Results
S. aureus grows unimpaired when co-cultured
with B. thuringiensis or K. oxytoca on solid agar
In a previous study, we applied replica plating of used
wound dressings to assess the topography of distinct S.
aureus types in chronic wounds of patients with EB [13].
Notably, this previous study was focused on S. aureus
only, and it did not take into consideration other co-
existing microbial species that are clearly evident upon
replica plating of wound dressings (Fig. 1A). Such co-
existing species were collected in the present study, using
the dressing of a chronic wound from a patient with
Junctional Epidermolysis Bullosa. This led to the identiﬁ-
cation of two S. aureus isolates with spa types t111 and
t13595 that grew in close proximity to B. thuringiensis
(Bt) and K. oxytoca (Ko) isolated from the same wound.
A zone inhibition experiment was employed to assess
possible competitive or bactericidal interactions between
these four wound isolates. As shown for the S. aureus
t111 and t13595 isolates in Fig. 1B, there was no growth
inhibition detectable when, respectively, Bt or Ko were
spotted onto blood agar plates that were conﬂuently
inoculated with S. aureus. The same was essentially
observed when Bt was spotted onto a conﬂuent inocu-
lated plate with Ko. Additionally, B. subtilis strain 168
was chosen as control based on the known growth inhi-
bition that B. subtilis 168 exerts on S. aureus due to pro-
duction of the bacteriocin sublancin [29]. Indeed, the
spotting of B. subtilis 168 onto the S. aureus cells caused
a clear growth inhibition zone (Fig. 1B). Furthermore, it
was noted that the growth of Bt and Ko occurred on top
of the S. aureus spread. To conﬁrm this observation,
serial dilution experiments were performed with mixed
cultures of S. aureus and Bt, or S. aureus and Ko. As
marked by the arrows in Fig. 1, colonies of S. aureus
were not only able to grow in the proximity of Bt and Ko
colonies, but some were observed to touch or even grow
on top of each other (Fig. 1C). This is fully consistent
with the situation encountered in the wound environ-
ment from which the bacteria were isolated and where
they thrive in close proximity (Fig. 1A).
S. aureus isolates t111 and t13595 are highly related
but not identical
As a ﬁrst step in the characterization of the selected S.
aureus t111 and t13595 isolates, their antibiotic resis-
tance proﬁles were determined. Both isolates were shown
to be resistant to tetracycline, ciproﬂoxacin and fusidic
acid. In addition, isolate t111 was found to be resistant to
trimethoprim and sulfamethoxazole (Supplemental
Table S1). These ﬁndings suggested that both isolates are
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very similar, but not identical. This was conﬁrmed by
whole-genome sequencing, revealing that the respective
core genomes differed only by 192 nucleotides. Genome
sequencing further revealed that both S. aureus isolates
belong to the sequence type 5 (ST5). Thus, the closest
related reference genome is the one of S. aureus strain
N315 which was, therefore, used for comparative geno-
mic analyses and annotation.
Although there are not many differences in the core
genomes of the t111 and t13595 isolates, a few of these
differences are noteworthy. For example, the fnbA and
fnbB genes of the t111 isolate were recombined into a
single gene. Isolate t13595 contained a point mutation in
agrA specifying the replacement of Gly148 with Asp, and
this mutation was correlated with an agr negative pheno-
type (i.e. unlike the t111 isolate, the t13595 isolate dis-
played no a, b or d-hemolysis). Frame shift mutations
were also observed in various other genes of the t13595
isolate, including the mutL gene for a DNA mismatch
repair protein, and genes such as sbi, araC, geh and
fnbA. For a more detailed comparison of the S. aureus
isolates with respect to different mobile genetic elements,
please refer to Supplemental Table S2.
Total numbers of S. aureus exoproteins are reduced
when S. aureus is co-cultured with Bt or Ko
Since the S. aureus, Bt and Ko isolates addressed in this
study were co-existent in the same wound environment
and are capable of growing in close contact in an in vitro
setting, we wanted to know whether and, if so, how they
inﬂuence each other. To address this question, we selected
a proteomics approach in which we focused our attention
on the extracellular proteome. Further, to simulate the con-
ditions in the human body, we selected the tissue culture
medium RPMI as the growth medium for our studies,
because S. aureus cells grown on RPMI or human plasma
display very similar genome-wide transcript proﬁles [30].
Thus, the S. aureus isolates t111 and t13595 were cultured
in three different conditions, namely in pure culture, or in
combination with either Bt or Ko. As expected from the
plating experiments, we observed only slight differences in
the logarithmic growth rates of the mixed cultures as
assessed by OD600 readings. For example, when S. aureus
was co-cultured with Bt, the overall growth seemed slightly
slower, while the opposite happened when S. aureus was
co-cultured with Ko (Figure S1). This can be explained by
the particular growth rates of the Bt and Ko isolates on
RPMI, where the growth rate of Bt in monoculture is rela-
tively slow, while that of Ko is relatively fast. Nevertheless,
the overall growth patterns of the co-cultures were similar
to those of the S. aureus pure cultures and, importantly,
they were highly reproducible. Hence, in all the experi-
ments, our reference for sampling was the S. aureus growth
curve in monoculture.
To obtain an overview of the behavior of the cultures,
we compared the total numbers of proteins detected by
LC-MS/MS in all conditions (Fig. 2A,B) and veriﬁed the
reproducibility of the biological replicates (Supplemental
Figure S2). This analysis revealed clear differences
between the pure and mixed cultures. Particularly, a total
Figure 1. Growth characteristics of the isolated bacteria on agar
plates. (A) Microbiome topography of culturable bacteria from
the wound dressing of a patient with Junctional EB. The used
dressing from a chronic wound was replica plated onto CLED
agar for isolation of the bacteria present. (B) Zone inhibition
experiments. Unimpaired staphylococcal growth upon spotting
of B. thuringiensis or K. oxytoca: (i) t111+Bt, (ii) t13595+Bt, (iii)
t111+Ko, and (iv) t13595+Ko. Unimpaired growth of K. oxytoca
upon spotting of B. thruingiensis (v). S. aureus growth inhibition
halo caused by spotting of B. subtilis 168 onto a lawn of staphylo-
coccal cells (vi; both S. aureus strains exhibited the same effect).
(C) Dilution and subsequent plating: (i) S. aureus colonies grow-
ing on top of larger colonies of B. thuringiensis; (ii) K. oxytoca and
S. aureus colonies growing in close proximity and occasionally
touching each other. Typical S. aureus colonies are marked with
arrows.
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of 64 extracellular proteins were detected in the S. aureus
t111 monoculture, while in combination with Bt only 26
extracellular staphylococcal proteins were detected, and
merely 16 when the t111 isolate was cultured with Ko.
Essentially the same was observed for the exoproteome
of the strain t13595, where 49 extracellular proteins were
found in the monoculture, and only 29 and 12 in the co-
cultures with Bt or Ko, respectively (Fig. 2A). We also
assessed the numbers of extracellular proteins detected
in the monocultures of Bt and Ko in comparison to the
co-cultures. The results indicate a decrease of »25% in
the number of Ko proteins found in the co-cultures with
S. aureus (Fig. 2B), but this effect was clearly not as
prominent as the effect of Ko on the staphylococcal exo-
proteome. On the other hand, the number of exoproteins
of Bt decreased only in the presence of the S. aureus t111
isolate but not in the presence of the t1359 isolate
(Fig. 2B). Of note, the exoprotein differences among the
cultures were also reﬂected in the absolute amounts of
protein detectable in the growth medium (Figure S3).
As a ﬁrst approach to characterize the identiﬁed
extracellular proteins, we assessed their predicted
Figure 2. Total numbers of extracellular proteins identiﬁed per culture. (A) Numbers of S. aureus t111 and t13595 exoproteins identiﬁed
in monocultures or upon co-culturing with B. thuringiensis (+Bt) or K. oxytoca (+Ko). (B) Numbers of B. thuringiensis and K. oxytoca exo-
proteins identiﬁed in monocultures or upon co-culturing with S. aureus t111 (+t111) or t13595 (+t13595) isolates. (C-F) Predicted subcel-
lular localization of proteins per strain in mono- or co-cultures. (C) 11, S. aureus t111 exoproteins; 11B, S. aureus t111 exoproteins upon
co-culture with B. thuringiensis; 11K, S. aureus t111 exoproteins upon co-culture with K. oxytoca. (D) 13, S. aureus t13595 exoproteins;
13B, S. aureus t13595 exoproteins upon co-cultures with B. thuringiensis; 13K, S. aureus t13595 exoproteins upon co-culture with K. oxy-
toca. (E) K, K. oxytoca exoproteins; K11, K. oxytoca exoproteins upon co-culture with S. aureus t111; K13, K. oxytoca exoproteins upon co-
culture with S. aureus t13595. (F) B, B. thuringiensis exoproteins; B11, B. thuringiensis exoproteins upon co-culture with S. aureus t111;
B13, B. thuringiensis exoproteins upon co-culture with S. aureus t13595.
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subcellular localization. For the two S. aureus isolates
and the Bt isolate, which are all three Gram-positive
bacteria, altogether 150 (50%) predicted cytoplasmic
proteins, 26 (9%) cell wall proteins, 74 (25%) mem-
brane proteins and 47 (16%) extracellular proteins
were identiﬁed in the exoproteome (Supplemental
Figure S4). For the Gram-negative Ko isolate, we
detected 50 (34%) predicted cytoplasmic, 25 (17%)
membrane, 1 (1%) extracellular, and 67 (46%) peri-
plasmic proteins (Supplemental Figure S4). Because of
the acute changes in the S. aureus exoproteome upon
co-culturing, we were interested in knowing which
predicted subcellular protein fractions were most
strongly affected in the various conditions. For both
S. aureus isolates, the fraction of predicted cyto-
plasmic proteins sharply decreased upon co-culturing,
and such proteins were even completely missing from
the co-culture of the t111 isolate with Ko (Fig. 2C,D).
On the contrary, the fraction of predicted cytosolic Bt
proteins in the extracellular proteome sharply
increased when co-cultured with S. aureus t13595,
while the numbers of predicted cytoplasmic proteins
of Ko in co-cultures with either of the two S. aureus
isolates were similar, showing a relatively slender
increase when S. aureus was present (Fig. 2E,F).
Co-cultured S. aureus, B. thuringiensis and K.
oxytoca isolates display species-speciﬁc
exoproteome changes in terms of biological
processes
Although both S. aureus isolates are closely related, par-
ticular variations in their exoproteomes were observed.
For example, the core exoproteome of the t111 isolate
included only 14 proteins (i.e. proteins constant in all
cultures), while the core exoproteome of the t13595 iso-
late included only nine proteins (Fig. 3 and Table S3).
Likewise, the biological processes in which these proteins
are involved were also different. The core exoproteome
of the t111 isolate was characterized by functions in pep-
tidoglycan catabolic processes, pathogenesis and cobala-
min transport, whereas the core exoproteome of the
t13595 isolate is involved in cell redox homeostasis, cell
wall organization, glucose metabolic processes, patho-
genesis, cell adhesion and glycine betaine biosynthetic
processes from choline.
Remarkably, there were not many staphylococcal
proteins expressed uniquely in the co-cultures. In
fact, there were no distinctive proteins detected in the
co-cultures with Ko for both S. aureus isolates
(Fig. 3A,B). For the co-cultures with Bt, we identiﬁed
only the translocase subunit SecG as a distinctive
feature in the growth medium of the t111 isolate, and
an uncharacterized distinctive protein was identiﬁed
in the growth medium of the t13595 isolate. In con-
trast, in the presence of the t111 or t13595 isolates,
Ko displayed 9 and 8 unique extracellular proteins,
respectively (Fig. 3D). The latter 9 proteins produced
in the presence of the t111 isolate were related, by
their gene ontologies, to chromosome condensation,
regulation of transcription, the phosphoenolpyruvate-
dependent sugar phosphotransferase system, and glyc-
erol ether metabolic processes. Similarly, Bt displayed
18 distinctive extracellular proteins in the presence of
the t13595 isolate (Fig. 3C). These proteins relate to
iron-sulphur cluster assembly, protein transport, cell
cycle, glucose and glycerol ether metabolic processes.
To further categorize the identiﬁed extracellular
proteins, we classiﬁed them according to their func-
tion and categorized them in one of the following six
groups: (1) cell envelope and cellular processes
(including cell wall/membrane, transport/binding pro-
teins and lipoproteins, signal transduction, membrane
bioenergetics, motility and chemotaxis, protein secre-
tion, cell division, cell adhesion, response to stress);
(2) information pathways (including DNA restriction/
modiﬁcation and repair, transcription and regulation,
ribosomal proteins, protein synthesis/modiﬁcation/
folding); (3) intermediary metabolism; (4) cell redox
homeostasis, (5) virulence factors; and (6) unknown
functions (see Supplemental Table S3).
In the diagrams of Fig. 4, the differences between
the S. aureus t111 and t13595 isolates in terms of the
functions of extracellular proteins are clearly evident;
while the t111 isolate seems to be more virulent, the
extracellular proteins of the t13595 are more involved
in processes related to cell redox homeostasis and
intermediary metabolism. Further, the core functions
of the t13595 isolate appear more diverse than those
of the t111 isolate. In the case of Ko, the overall pic-
ture indicates that this bacterium’s exoproteome is
strongly involved in cell envelope and cellular pro-
cesses, especially processes relating to the transport
and binding of proteins and lipoproteins (Supplemen-
tal Figure S5A). For Bt, we observed that the response
towards the co-cultured S. aureus isolates was consid-
erably different. In particular, the extracellular Bt pro-
teins related to many more different functions when
Bt was co-cultured with the t13595 isolate than when
Bt was co-cultured with the t111 isolate. Interestingly,
like the S. aureus t13595 isolate co-cultured with Bt,
Bt also exhibited many extracellular proteins related
to redox homeostasis when co-cultured with the
t13595 isolate (Supplementary Figure S5B).
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Particular exoproteins of S. aureus, K. oxytoca
and B. thuringiensis show quantitative changes in
mono- or co-cultures
Conceivably not all the differences in the exoproteome
composition of mono- and co-cultured S. aureus, Ko and
Bt are absolute, but also quantitative differences may exist
for particular exoproteins. Therefore, we comparatively
assessed signiﬁcant fold-changes in the exoproteins
detected in mono- and co-cultures by mapping their spec-
tral counts from all replicates using volcano plots (Supple-
mental Figure S6). The results of this analysis, presented
in Table 1, indicate that there were 11 exoproteins signiﬁ-
cantly ‘upregulated’ in the S. aureus monocultures com-
pared to the co-cultures with Bt or Ko. These included S.
aureus proteins, such as elongation factor Ts, triosephos-
phate isomerase, thioredoxin reductase, 2,3-bisphospho-
glycerate-dependent phosphoglycerate mutase and a
Figure 3. Relationships among cultures. The diagrams show the number of proteins identiﬁed in all cultures and those proteins shared
in the different conditions. (A) Total number of S. aureus t111 proteins in monoculture (11) and in co-culture with B. thuringiensis (11B)
or K. oxytoca (11K); (B) Total number of S. aureus t13595 proteins in monoculture (13) and in co-culture with B. thuringiensis (13B) or K.
oxytoca (13K); (C) Total number of B. thuringiensis proteins in monoculture (B) and in co-culture with S. aureus t111 (B11) or S. aureus
t13595 (B13); (D) Total number of K. oxytoca proteins in monoculture (K) and in co-culture with S. aureus t111 (K11) or S. aureus t13595
(K13); (E) Total number of S. aureus proteins in monoculture (11) or (13) and in co-culture (11+13).
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secreted b-lactamase. In the case of Ko, 22 exoproteins
were present in signiﬁcantly different amounts when
mono and co-cultures were compared. Here, 17 exopro-
teins of Ko were signiﬁcantly upregulated in the
monocultures, whereas 5 other exoproteins of Ko were
signiﬁcantly upregulated in the co-cultures with S. aureus.
The latter proteins are mostly involved in carbohydrate
metabolism. Also in the case of Bt, 22 exoproteins were
Figure 4. Overview of the predicted functions of the exoproteins found in all staphylococcal cultures. Diagram (A) depicts only S. aureus
t111 proteins. The area on the top shows the proteins detected only in monoculture, while the lower left area shows a single protein
detected when t111 was co-cultured with B. thuringiensis. Likewise, diagram (B) shows exclusively the proteins that belong to S. aureus
t13595 in monoculture and co-culture with B. thuringiensis or K. oxytoca. Diagram (C) depicts the proteins of S. aureus t111 and t13595
grown in monoculture in the bottom areas, whilst the upper area shows the proteins identiﬁed upon co-culturing both S. aureus iso-
lates. In the latter area, the circles are represented as pie charts. The charts show the percentage of proteins that belong to each isolate.
For the unknown proteins (in grey), 50% belong to t111, 37% to t13595, and 12.5% to both of them; for the cell envelope proteins
(blue) 67% belong to t111 and 33% to both isolates; for proteins involved in intermediary metabolism (green), 25% belong to t111 and
75% to t13595; and for information pathways proteins (yellow), 50% belong to t111 and 50% to both isolates.
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Table 1. Summary of differentially detected extracellular proteins among the different cultures. Volcano plots (Supplemental Figure S6)
displayed P values (-log10) versus fold changes (log2) of the normalized spectral counts. Folds 1 represent proteins that were signiﬁ-
cantly up-regulated in the co-cultures and folds >1 represent proteins that were signiﬁcantly up-regulated in monoculture.
Species Protein Function / Gene ontology Fold p value
S. aureus Beta-lactamase Hydrolysis of beta-lactamic ring 12.81 0.041
S. aureus Phosphocarrier protein HPr Phosphoenolpyruvate-dependent sugar
phosphotransferase system. Serine/threonine kinase
activity. Regulation of transcription, DNA-templated
6.61 0.009
S. aureus Fructose-bisphosphate aldolase class 1 Glycolytic process 12.89 0.042
S. aureus Elongation factor Ts Binds to aminoacyl-tRNA. Protein biosynthesis 29 0.034
S. aureus Triosephosphate isomerase Gluconeogenesis. Glycolytic process. Pentose-
phosphate shunt
18 0.038
S. aureus 2,3-bisphosphoglycerate-dependent phosphoglycerate
mutase
Gluconeogenesis. Glycolytic process 16.80 0.048
S. aureus Cysteine synthase Cysteine biosynthetic process from serine 13 0.045
S. aureus Phosphate acetyltransferase Acetyl-CoA biosynthetic process 15.60 0.039
S. aureus Thioredoxin reductase Removal of superoxide radicals 17 0.040
S. aureus Putative universal stress protein SSP1056 Response to stress 13 0.046
S. aureus D-alanine-poly(phosphoribitol) ligase subunit 2 Cell wall organization. Lipoteichoic acid biosynthetic
proces. Regulation of cell shape
6 0.039
K. oxytoca Uncharacterized protein Unknown 2.68 0.003
K. oxytoca Colicin I receptor Bacteriocin transport. Iron assimilaiton. Siderophore
transmembrane activity
1.63 0.036
K. oxytoca Glyceraldehyde-3-phosphate dehydrogenase Glucose metabolic process. Glycolytic process 0.33 0.044
K. oxytoca TonB-dependent hemin, ferrichrome receptor Transporter activity 1.79 0.024
K. oxytoca Glutathione-binding protein GsiB ABC transporter complex (periplasmic space) 1.26 0.043
K. oxytoca Phosphoglycerate kinase ATP binding. Glycolytic process 0.37 0.030
K. oxytoca Glycine betaine-binding periplasmic protein Transporter activity 1.81 0.010
K. oxytoca Protein TolB Bacteriocin transport. Uptake of colicins (group A) 1.50 0.029
K. oxytoca Leucine-speciﬁc-binding protein L-alpha-amino acid transmembrane transport. 2.16 0.002
K. oxytoca Pyruvate kinase I Glycolysis. Magnesium, potassium and ATP-binding. 0.23 0.038
K. oxytoca Glutamine-binding periplasmic protein Amino acid transport. 1.49 0.040
K. oxytoca 6-phosphogluconolactonase Pentose phosphate pathway. 0.5 0.022
K. oxytoca Osmotically-inducible lipoprotein E Possibly involved in maintaining the structural integrity
of the cell envelope.
4.75 0.002
K. oxytoca Periplasmic serine endoprotease DegP Degrades transiently denatured and unfolded proteins
accumulated in the periplasm in stress conditions
4.86 0.002
K. oxytoca Uncharacterized protein Unknown 10 0.004
K. oxytoca Periplasmic trehalase Cellular hyperosmotic response 3.60 0.049
K. oxytoca Uncharacterized protein Unknown 6.67 0.011
K. oxytoca Uncharacterized protein Unknown 0.13 0.031
K. oxytoca Peptidoglycan-associated lipoprotein Possibly bacterial envelope integrity 3.20 0.019
K. oxytoca Chaperone protein MrkB Cell wall organization. Chaperone-mediated protein
folding. Pilus organization.
5.33 0.045
K. oxytoca MltA-interacting protein Peptidoglycan byosynthetic process 24 <0.001
K. oxytoca Thiamine-binding periplasmic protein ATP binding. Thiamine transport. 8 0.010
B. thuringiensis Uncharacterized protein Unknown 14.61 0.001
B. thuringiensis Sulfatase Sulfuric ester hydrolase activity 3.59 0.008
B. thuringiensis Internalin The function of this domain is not clear 4.12 <0.001
B. thuringiensis Endopeptidase lytE, putative lytE The function of this domain is not clear 2.08 0.023
B. thuringiensis Peptidase M4 thermolysin The function of this domain is not clear 2.70 <0.001
B. thuringiensis Enolase Glycolytic process 4.44 0.043
B. thuringiensis Bacillolysin Extracellular zinc metalloprotease 4.40 0.002
B. thuringiensis Extracellular solute-binding protein family 5 The function of this domain is not clear 3.37 0.005
B. thuringiensis VanW Vancomycin resistan protein W. The function is not
clear.
2.80 0.045
B. thuringiensis Uncharacterized protein Unknown 3.76 0.014
B. thuringiensis Uncharacterized protein Unknown 25 <0.001
B. thuringiensis Uncharacterized protein Unknown 5.33 0.026
B. thuringiensis Uncharacterized protein Unknown 14 0.011
B. thuringiensis Oligopeptide transporter, periplasmic-binding protein ABC transporter complex 17 0.001
B. thuringiensis Periplasmic component of efﬂux system Transmembrane transport 18 <0.001
B. thuringiensis Camelysin Metallo peptidase MEROPS family M73 The function of this domain is not clear 7.33 0.031
B. thuringiensis Flagellar hook-associated protein 3 Bacterial-type ﬂagellum-dependent cell motility 11 0.014
B. thuringiensis Uncharacterized protein Unknown 10 0.035
B. thuringiensis Uncharacterized protein Unknown 8 0.010
B. thuringiensis Uncharacterized protein Unknown 7 0.021
B. thuringiensis Foldase protein PrsA 2 Protein folding 9 0.008
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present in signiﬁcantly different amounts when mono and
co-cultures were compared (Table 1). Interestingly, 21 of
these Bt exoproteins were signiﬁcantly ‘upregulated’ in the
monocultures compared to the co-cultures with S. aureus.
The functions of these proteins were rather diverse,
including the cell wall hydrolase LytE, three different pro-
teases, and the protein folding catalyst PrsA.
Discussion
Our present co-culturing approach represents an oppor-
tunity to study changes in protein diversity as a result of
inter-bacterial relationships that can, to a certain extent,
reﬂect the natural situation in a wound. In principle, the
in vitro growth characteristics of S. aureus colonies over
B. thuringiensis or K. oxytoca colonies suggest adaptive
mechanisms for all species. From the proteome perspec-
tive, one mechanism that stands out is the depletion of
staphylococcal cytoplasmic proteins from the exopro-
teomes of co-cultures upon co-culture with Bt or Ko.
Proteomic analysis also revealed two uniquely detectable
exoproteins in the co-cultures with Bt. The exoprotein
found in the co-culture of S. aureus t111+Bt was SecG, a
subunit of the heterotrimeric complex SecYEG. This
complex serves as a membrane channel for translocation
of secretory proteins in an unfolded state [31]. In S.
aureus, SecG is of importance since secG deletion
mutants displayed impaired secretion of several wall-
bound proteins and abundant exoproteins [32]. Despite
its known function in protein secretion, the reason for
the unique detection of SecG in the t111-Bt exopro-
teomes is presently not clear. Additionally, in S. aureus
t13595+Bt co-cultures an uncharacterized protein that
resembles a control factor of the competence regulator
ComK, named YlbF/YmcA, was found. This protein is
known to be involved in bioﬁlm formation by other
Gram-positive and archaeal organisms. Further charac-
terization of these two proteins might help us to under-
stand why they are present in the exoproteome when S.
aureus is co-cultured with Bt.
While the exoproteome of S. aureus in monoculture
was previously found to contain numerous typically
cytoplasmic proteins [17, 33–38], this is not an exclusive
trait of S. aureus. The exoproteomes of other Gram-posi-
tive bacteria, such as B. subtilis, Clostridium difﬁcile,
Corynebacterium diphtheria, Group A Streptococcus,
Mycobacterium tuberculosis and Streptomyces lividans,
but also Gram-negative bacteria like Porphyromonas gin-
givalis, have been associated with high numbers of such
typically cytoplasmic proteins.[36, 39–43] In B. subtilis,
this observation has been explained by a combination of
high cell lysis propensity, increased cell wall turnover
and/or autolysin activity [44]. It has also been proposed
that the ‘liberation’ of typical cytoplasmic proteins that
lack the prototype signal peptides of proteins exported
via the general Sec pathway for protein secretion could
be facilitated by as yet unidentiﬁed alternative pathways,
also referred to as ‘non-classical secretion systems’
[45–50]. For example, it is conceivable that, besides the
well-characterized endolysins, the expression of pro-
phage-encoded holins or holin-like proteins might have
a role in the liberation of otherwise cytosolic proteins
[42,50]. The release of cytosolic proteins due to the large
pores formed by holins is still somewhat debated, since it
has not been extensively studied in Gram-positive organ-
isms. Nevertheless, the presence of additional holins
could, thus, at least partially explain the elevated number
of cytoplasmic proteins found in the growth medium of
the S. aureus t13595 isolate compared to the t111 isolate.
Yet, it has been shown for B. subtilis that engineered
strains lacking all prophages still release typical cyto-
plasmic proteins into their growth medium [52]. Clearly,
for the bacterial isolates investigated in the present study,
it remains to be deﬁned which particular mechanisms
contribute, individually or synergistically, to the
observed non-classical secretion phenomenon and to
what extent.
Interestingly, the common denominator between the
presently identiﬁed S. aureus exoproteome and that of its
‘wound mates’ is the presence of housekeeping enzymes,
particularly glycolytic enzymes. For instance, glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) found in the
S. aureus t13595, Bt and Ko cultures, has also been located
on the surface of other pathogenic bacteria like group A
streptococci, and enteropathogenic E. coli where it can
serve either as a binding protein or as signal transduction
initiator in epithelial cells [53–55]. Cell wall-associated pro-
teins like enolase (displayed in the same cultures) have
been reported to bind to plasminogen both in Gram-posi-
tive (Streptococcus pneumoniae) and Gram-negative (Acti-
nobacillus actinomycetemcomitans) bacteria [56, 57]. Other
multifunctional ‘moonlighting’ proteins like fructose-
bisphosphate aldolase, identiﬁed in S. aureus t111 cultures,
are recognized to play a role in adhesion to mammalian
cells and binding of human plasminogen by several bacte-
rial species, like S. pneumoniae, M. turberculosis, and Neis-
seria meningitidis [58]. Similarly, the elongation factor (EF)
Tu, a guanosine nucleotide binding protein important for
protein synthesis, was detected on the surface of Myco-
plasma pneumoniae and Lactobacillus johnsonii, where it
was involved in ﬁbronectin- and mucin-binding, respec-
tively [59, 60]. Furthermore, an immunoproteomic study
of bacteremia showed that six housekeeping enzymes and
EF-Tu were linked to leukopenia caused byKlebsiella pneu-
monia [61]. Altogether, these ﬁndings imply that proteins,
which were originally considered to be restricted to the
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cytoplasm, may also be important for virulence enhance-
ment and invasive disease [50, 62]. Indeed, for S. aureus,
such proteins have previously been implicated in virulence,
epidemiology and intracellular survival [46–48, 50, 63].
By tracking the S. aureus-speciﬁc exoproteome, we
observed that especially the cytoplasmic protein fractions
were depleted from the exoproteome in co-cultures. This
suggests that there might be either an altered localiza-
tion, decreased cell lysis, enhanced proteolysis or con-
sumption of these proteins by the other organism in the
respective co-culture. In the literature, a loss of the cyto-
plasmic exoproteome fraction was recently associated to
the latter. When studying marine bacteria in mixed cul-
tures, Christie-Oleza et al. showed that extracellular cyto-
plasmic proteins from Synechococcus are notably reduced
when Roseobacter strains are present [64]. Their study
also reported an abundance of active transporters and
ﬂagellar proteins of Roseobacter during co-culturing.
Such a situation could potentially also apply to K. oxy-
toca and B. thuringiensis as the present data suggests
that, when grown in a nutrient-limited environment,
these bacteria might act as scavengers of carbon and
nitrogen sources, particularly by degrading and assimi-
lating extracellular staphylococcal proteins. If so, this
would suggest that, at least in a closed system like the
one we established in vitro, nothing goes to waste and
that the carbon and nitrogen ﬁxing characteristics of Bt
and Ko are perhaps a distinguishable reﬂection of short-
term interspecies interactions. Nevertheless, we cannot
exclude the possibility that there could also be less S.
aureus cell lysis during co-culture. One way to verify the
idea that Bt and Ko consume extracellular proteins of S.
aureus, may involve the metabolic labeling of S. aureus
proteins with particular isotopes, providing these pro-
teins to Bt or Ko cultures, and investigating the incorpo-
ration of the isotopes into Bt or Ko proteins or
metabolites. Likewise, interactions between S. aureus
and Bt or Ko could be investigated by transcriptomics
and metabolomics. Irrespective of the molecular back-
ground of our observations, the depletion of S. aureus
proteins from the exoproteome upon co-culturing has an
important implication for the virulence of this bacterium
as exoproteins should be considered as the prime reser-
voir of virulence factors [17, 50].
Beyond the known proteome heterogeneity [33, 34,
37]. and the genetic diversity of the colonizing staphylo-
coccal strains [15, 65], we found amutLmutation indica-
tive of impaired mismatch repair and other
hypermutable traits in our S. aureus t13595 isolate [66].
This ﬁnding allows us to place the relationships between
the investigated S. aureus isolates in a broader perspec-
tive, where it is of note that the presently investigated
bacterial isolates from an EB patient were obtained upon
one-time sampling of a >8 months existing chronic
wound. Importantly, it has been hypothesized that
hypermutable strains play roles in species persistence
and chronic infection [67, 68] and they could perhaps
also favor the development of antibiotic resistance [69–
71]. In the context of the long-term colonization of
chronic wounds of EB patients by S. aureus, the inﬂuence
of mutations on the intra-species heterogeneity should
be considered in view of microbial social behavior and
the consequences for ﬁtness that particular mutations
may provide [72]. Interestingly, with respect to the
observed proteomic proﬁles, the S. aureus t111 isolate
seems to foster a committed production of metabolically
costly siderophores, virulence factors and cell adhesion
molecules, while the t13595 isolate shows a more ‘recalci-
trant’ performance focusing only on its metabolism and
homeostasis. Moreover, during co-culturing of the t111
and t13595 isolates, we did not observe any protein over-
expression, contrary to what was observed for the mono-
cultures. This outcome is suggestive of a cooperative
behavior. Therefore, it is tempting to hypothesize that
the genetic variability as displayed by the ‘selﬁsh’ t13595
isolate may be beneﬁcial for the spread or persistence of
S. aureus as a wound-colonizing species [73].
To the best of our knowledge, our research represents
the ﬁrst explanatory analysis of S. aureus exoproteomic
shifts while in co-culture with wound-coexisting bacteria.
Collectively, our ﬁndings point out the importance of
studying bacteria in a broader biological context. It is evi-
dent that, for example, the growth rates of the four iso-
lates explored here are not necessarily the same, and
therefore it is not possible to compare the exoproteome
of all investigated isolates at exactly the same growth
stage. However, this situation is also true in a wound
environment where not all co-existing microbes are
completely synchronized or exist in equal numbers.
Hence, the present data should be interpreted as one of
many possible scenarios in which bacteria interact with
each other with no apparent antagonistic relationships.
Because of the complexity of the wound environment
and the peculiarities of each wound, it is difﬁcult to
establish a standard deﬁnition of the nutrients present in
a wound. For example, temperature in a wound can
inﬂuence local vasodilation and therefore the availability
of nutrients. Furthermore, the biomolecules are primar-
ily at the disposal of host cells rather than bacteria that
have to compete for the nutrient restriction [74]. In the
present investigations, we have presented a scenario that
simulates the conditions in human plasma, which relies
on bacteria cultivated under shaking and not static con-
ditions. Accordingly, the present culture conditions may
not exactly reﬂect the situation in chronic wounds of an
EB patient. However, it seems reasonable to assume that
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in the wound environment, cytosolic bacterial proteins
could represent an important foundation for micro-
biome cross talk and homeostasis. Altogether, our
experiments introduce an attractive avenue to explore
possible pre- and probiotic targets, such as quorum sens-
ing- or quorum quenching-related factors or bacterial
growth factors that can either hinder the invasion by
pathogenic bacteria, or enhance the presence of non-
pathogenic microbes that may prevent infections and
could even enhance wound healing.
Material and methods
Ethical approval
The local medical ethics committee (METc) of the Uni-
versity Medical Center Groningen (UMCG) approved of
the collection of non-invasive samples from patients
with EB on the basis of obtained written informed
patient consent. The experiments were conducted in
accordance with the guidelines of the Declaration of Hel-
sinki. All samples were anonymized.
Bacterial isolation, identiﬁcation and culture
conditions
The used bandage from a chronic wound of a Dutch
patient with Junctional Epidermolysis Bullosa was col-
lected. The bandage was replica-plated with gentle pres-
sure for 10 seconds onto CLED agar (Oxoid) using
bioassay plates (245 £ 245 £ 245 ;mm; Nunc). After
48 h of incubation at 37C, colonies were selected and
replated onto blood agar plates for identiﬁcation. Bacte-
rial colonies were identiﬁed by matrix-assisted laser
desorption/ionization-time-of-ﬂight (MALDI-TOF) MS,
using a MALDI Biotyper® (Bruker Corporation, Billerica,
USA) as previously described [75]. All isolates were
stored with 10% glycerol at ¡80C.
To investigate whether the studied bacteria secrete
compounds that interfere with each other’s growth,
blood agar plates were spread with pure overnight cul-
tures of S. aureus isolates with an optical density at
600 nm (OD600) of 0.5 to obtain a conﬂuent lawn of cells.
Then, after 5 min, 10 mL aliquots of pure overnight cul-
tures of B. thuringiensis, K. oxytoca or Bacillus subtilis
168 (OD600 0.5) were applied to the center of the agar
plate. For viable plate counting and the preparation of
extracellular protein extracts, bacterial strains were
grown overnight on Tryptic Soy Broth (TSB) under vig-
orous shaking at 37C. The cultures were then diluted to
an OD600 of 0.05 in pre-warmed RPMI medium without
phenol red (GE Healthcare). Cultivation continued in a
water bath under constant shaking (80–85 rpm) at 37C
until cultures reached an OD600 of §0.5. Main cultures
were again diluted in 120 mL pre-warmed RPMI
medium under the same conditions. Monocultures were
started with an initial OD600 of 0.05 while co-cultures
were inoculated with an OD600 of 0.025 of each isolate to
a total of 0.05. Given that an OD600 of 0.5 contained a
total of »200 £ 106 colony forming units per mL (CFU/
mL) for t111, t13595 and Ko, and »15 £ 106 CFU/mL
for Bt, inoculated cultures corresponded to »20 £ 106
CFU/mL for t111, t13595 and Ko and to »1.5 £ 106
CFU/mL for Bt.
For proteome analyses and determination of CFU/
mL, samples were collected at 90 min within the station-
ary growth phase. The ratios of different bacteria sam-
pled from the co-cultures remained nearly the same with
the exception of the co-cultures of S. aureus and K. oxy-
toca, where K. oxytoca grew 1.5 times faster than t111
and 1.7 times faster than t13595.
Genomic DNA extraction, genome sequencing
and analysis
Libraries for whole genome sequencing were prepared
from S. aureus t111, t13595, B. thuringiensis, and K. oxy-
toca DNA with the Nextera XT v2 kit, and run on Illu-
mina next generation sequencing platforms (MiSeq)
according to the manufacturers’ instructions (Illumina,
San Diego, CA, USA). Read data for the study isolates
have been deposited in the National Center for Biotech-
nology Information (NCBI) under accession number
SRP094393. The respective .fastq ﬁles were submitted for
de novo sequence assembly using CLC Genomics Work-
bench v7.0.4 (CLC bio A/S, Aarhus, Denmark) after
quality trimming (Qs > 28) with optimal word sizes
based on the maximum N50 value. De novo assembled
contigs of the S. aureus isolates were imported into the
Seqsphere+ software version 1.0 (Ridom GmbH,
W€urzburg, Germany) for in silico multi-locus sequence
typing (MLST) and spa typing as previously described
[76, 77]. Automatic genome annotation was done on the
rapid annotation using subsystem technology (RAST)
server 2.0 for all the genomes [78, 79]. De novo assem-
bled genomes of sequenced isolates were queried against
the closest related reference genome of S. aureus strain
N315 (GenBank: NC_007795.1), B. thuringiensis serovar
konkukian str. 97–27 (GenBank: NC_017200), and K.
oxytoca strain E718 (GenBank: NC_018106) using
blastN in the WebACT comparison tool (http://www.
webact.org/WebACT/prebuilt#) and analyzed in detail
by the Artemis Comparison Tool (ACT) software [80,
81]. Similarity matches were ﬁltered based on their
length (100 kb segments) and percentage similarity
scores, and only the ﬁltered hits with at least 80%
VIRULENCE 373
sequence similarity were then displayed by ACT (e-value
of 10.00000) and analyzed in detail.
Preparation of protein extracts
All samples were collected in duplicate according to
the growth curves of the S. aureus isolates after
90 min of stationary growth. Cells were removed by
centrifugation (10 min, 8000 x g, 4C) from 2 mL
culture aliquots and the supernatant was subsequently
ﬁltrated with a 0.22 mm ﬁlter (GE Healthcare Sys-
tems, Little Chalfont, United Kingdom). Proteins
were precipitated with 10% w/v TCA on ice at 4C
overnight. The precipitates were harvested by centri-
fugation (20 min, 8000 £ g, 4C) and washed with
ice-cold acetone. The protein pellets were dried at
room temperature and stored at ¡20C until further
use. Total protein concentration was determined with
the Pierce BCA protein quantiﬁcation assay (Thermo-
Fisher Scientiﬁc). Protein pellets were suspended in
50 mM ammonium bicarbonate buffer (Fluka, Buchs,
Switzerland). As reducing agent, 10 mM dithiothreitol
(Duchefa Biochemie, Haarlem, the Netherlands) was
used for 30 min, and as alkylating agent, 10 mM
iodoacetamide (Sigma-Aldrich, St. Louis, USA) was
used for 30 min in the dark. Further, overnight incu-
bation with 80 ng of trypsin (Promega, Madison,
USA) at 37C was followed by the addition of 0.1%
triﬂuoroacetic acid (TFA, Sigma-Aldrich, St. Louis,
USA) to end the digestive reaction. The samples were
desalted by Zip-Tip puriﬁcation (Millipore, Billerica,
USA) as previously described by Dreisbach et al. [82].
The ﬁnal eluates were concentrated using a vacuum
centrifuge (Eppendorf, Hamburg, Germany) and
stored at 4C until further use.
Mass spectrometry and data analysis
Tryptic peptides were separated by reversed phase liquid
chromatography (LC). LC-MS/MS analyses were per-
formed using a nanoACQUITY UPLC system (Waters,
Milford, MA) coupled to an LTQ XL Orbitrap mass
spectrometer (Thermo Fisher Scientiﬁc,Waltham, MA)
creating an electro spray ionization through a Picotip
Emitter (SilicaTip, FS360-20-10 Coating P200P, New
Objective). Speciﬁcally, the peptides were loaded onto a
trap column (Symmetry C18, 5 mm, 180 mm inner diam-
eter £ 20 mm, Waters). Elution was performed onto an
analytical column (BEH130 C18, 1.7 mm, 100 mm inner
diameter £ 100 mm, Waters) by a binary gradient of
buffer A (0,1% (v/v) acetic acid) and B (0,1% (v/v) acetic
acid in acetonitrile) over a period of 80 min with a ﬂow
rate of 400 nL min¡1. A stepped gradient was applied.
For MS/MS analysis a full survey scan was recorded in
the Orbitrap (m/z 300–2000) with a resolution of 30,000.
The ﬁve most abundant precursor ions from each survey
scan were consecutively isolated in the LTQ XL and frag-
mented via collision induced dissociation (CID). Precursors
were dynamically excluded for 30 s and unassigned charge
states as well as singly charged ions were rejected [83].
Internal calibration was applied (lock mass 445.120025 m/
z). Database searching was done with Sorcerer-SEQUEST 4
(Sage-N Research, Milpitas, USA). After extraction from
the raw ﬁles, .dta ﬁles were searched with Sequest against a
concatenated target-pseudoreversed decoy database with a
set of common laboratory contaminants. The target data-
base was the Uniprot reference database (downloaded on
September 2014) of B. thuringiensis (5815 protein hits), K.
oxytoca (5663 protein hits), S. aureus t111 (2574 protein
hits) and S. aureus t13595 (2625 protein hits). The .out
ﬁles were compiled with Scaffold 4 (version Scaffold_4.4.1,
Proteome Software Inc., Portland, OR). Protein identiﬁca-
tion criteria were carried out as speciﬁed by Hempel et al.,
[83]. but with the following XCorr values:  2.2, 3.3, 3.75
for doubly, triply and higher charged peptides. To allow
protein abundance comparisons between samples, Scaffold
MS/MS data were normalized by adjusting the sum of the
selected quantitative values for all proteins in the list within
each MS sample to a common value: the average of the
sums of all MS samples present in the experiment. This
was achieved by applying a scaling factor for each sample
to each protein or protein group adjusting in this way the
selected value to a normalized “Quantitative Value” [84].
These values were exported from Scaffold and further
curated in spreadsheets for analysis (Table S3). The MS
raw data has been deposited to the ProteomeXchange Con-
sortium via the PRIDE partner repository with the dataset
identiﬁer PXD005596 [Username: reviewer87282@ebi.
ac.uk / Password: byH5iQGT]. Volcano plots used the nor-
malized values for calculating the fold-changes in each pro-
tein among the monoculture samples versus the co-culture
samples.
Bioinformatic analyses
Subcellular protein localization was predicted with
TMHMM (version 2.0) [85, 86], SignalP (version 4.1)
[87], LipoP (version 4.1) [88], PSORTb (version 3.0)
[89], and ClusbSub-P (version 2.18.3) [90]. Proteins with
ambiguous predictions were manually curated by inspec-
tion of their individual sequences with InterProScan 5
(version 49.0) [91]. For interpretation and visualization
of biologically relevant protein functions, the gene ontol-
ogy (GO) terms identiﬁed for the investigated exopro-
teomes were imported into the freely available online
Revigo software (http://revigo.irb.hr/) [92].
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Biological and chemical safety
S. aureus and K. oxytoca are biosafety level 2 (BSL-2)
microbiological agents and were accordingly handled fol-
lowing appropriate safety procedures. All experiments
involving live bacteria and chemical manipulations of
bacterial protein extracts were performed under appro-
priate containment conditions. All chemicals and
reagents used in this study were handled according to
the local guidelines for safe usage and protection of the
environment.
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